Entry |
|
Name |
Giminabant (USAN/INN) |
Formula |
C26H22Cl2N4
|
Exact mass |
460.1222
|
Mol weight |
461.38
|
Structure |

|
Class |
Gastrointestinal agent
DG01705 Anoretic
DG01754 Cannabinoid receptor inverse agonist
|
Efficacy |
Antiobesity, Cannabinoid receptor inverse agonist |
Comment |
Treatment of obesity
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Gastrointestinal agent
DG01705 Anoretic
DG01754 Cannabinoid receptor inverse agonist
D10314 Giminabant
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 32
1 C1x C 19.2500 -15.8200
2 N1y N 19.2500 -17.2200
3 C1x C 18.0600 -17.9200
4 C1y C 16.8000 -17.2200
5 N1y N 16.8000 -15.8200
6 C1x C 18.0600 -15.1200
7 C8y C 15.6100 -17.9200
8 C1c C 20.4400 -17.9200
9 C8y C 21.6300 -17.2200
10 C1a C 20.4400 -19.3200
11 C8x C 21.6300 -15.8200
12 C8x C 22.8900 -15.1200
13 C8y C 24.0800 -15.8200
14 C8x C 24.0800 -17.2200
15 C8x C 22.8900 -17.9200
16 C3b C 25.2700 -15.1200
17 N3a N 26.5300 -14.4200
18 C8x C 15.6100 -19.3200
19 C8x C 14.4200 -20.0200
20 C8y C 13.1600 -19.3200
21 C8x C 13.1600 -17.9200
22 C8x C 14.4200 -17.2200
23 X Cl 11.9700 -20.0200
24 C8y C 15.6100 -15.1200
25 C8x C 14.4200 -15.8200
26 C8x C 13.1600 -15.1200
27 C8y C 13.1600 -13.7200
28 C8x C 14.4200 -13.0200
29 C8y C 15.6100 -13.7200
30 X Cl 16.8000 -13.0200
31 C3b C 11.9700 -13.0200
32 N3a N 10.7800 -12.3200
BOND 35
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 5 6 1
6 1 6 1
7 4 7 1 #Up
8 2 8 1
9 8 9 1
10 8 10 1 #Up
11 9 11 2
12 11 12 1
13 12 13 2
14 13 14 1
15 14 15 2
16 9 15 1
17 13 16 1
18 16 17 3
19 7 18 2
20 18 19 1
21 19 20 2
22 20 21 1
23 21 22 2
24 7 22 1
25 20 23 1
26 5 24 1
27 24 25 2
28 25 26 1
29 26 27 2
30 27 28 1
31 28 29 2
32 24 29 1
33 29 30 1
34 27 31 1
35 31 32 3
|